boston scientific corp. Resources | BNET
On ZDNet: Hackers go to Mars

BNET Industries

Boston Scientific Corp. (BSX) is in the Health Care Industry

Revenue
Dec 31 2007
$8.3B
Profit
Dec 31 2007
($495.0M)
Market Cap
Jul 22 2008
$18.3B

Latest News and Analysis

Additional Resources

  • Antisoma appoints Michael Lewis as a Non-Executive Director

    9 July 2008 London, UK: Antisoma plc (LSE: ASM; USOTC: ATSMY) todayannounces the appointment of Mr Michael Lewis as a Non-ExecutiveDirector with immediate effect. Mr Lewis is currently President for Europe, Middle East and Africaand was also Head of Global Marketing for the medical device companyGambro, with responsibility for USD...

    Articles 2008-07-09

  • Joe Hallow Named to the Board of Directors of BridgePoint Medical, LLC

    LEXINGTON, Ky., July 8 /PRNewswire/ -- BridgePoint Medical, LLC, an independently owned prosthetic and orthotic company, today announced that Joseph F. Hallow, III has been elected to serve on its Board of Directors. Mr. Hallow currently serves as president of Bissell Hotels in Charlotte, North Carolina. As president and...

    Articles 2008-07-08

  • Boston Scientific Announces FDA Approval for PROMUS™ Everolimus-Eluting Coronary Stent System

    Boston Scientific only company to offer choice of two distinct drugs on separate drug-eluting stent platforms NATICK, Mass., July 2 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that the U.S. Food and Drug Administration FDA has approved the PROMUSTM Everolimus-Eluting Coronary Stent System for the treatment...

    Articles 2008-07-02

  • FDA Approves Abbott's XIENCE™ V Drug Eluting Stent

    XIENCE V, Only Drug Eluting Stent to Demonstrate Superiority Over Market-Leading Stent in Clinical Trials, Now Available in United States for Treatment of Coronary Artery Disease ABBOTT PARK, Ill., July 2 /PRNewswire-FirstCall/ -- Abbott today announced that the U.S. Food and Drug Administration FDA approved the XIENCETM...

    Articles 2008-07-02

  • Boston Scientific To Webcast Conference Call Discussing Second Quarter Financial Results

    NATICK, Mass., June 26 /PRNewswire-FirstCall/ -- Boston Scientific Corporation will webcast its conference call discussing financial results for the second quarter ended June 30, 2008 on Tuesday, July 22, at 8:30 a.m. ET. The call will be hosted by Jim Tobin, President and Chief Executive Officer,...

    Articles 2008-06-26

  • Maria Sainz Elected to Orthofix International Board of Directors

    BOSTON -- Orthofix International N.V. (NASDAQ:OFIX) announced today that Maria Sainz has been elected to the company's Board of Directors. Ms. Sainz currently serves as the President and CEO of Concentric Medical. Prior to joining Concentric Medical she was President of Guidant Corporation's Cardiac Surgery Division, and a...

    Articles 2008-06-25

  • Boston Scientific Welcomes Progress on Pain Care Legislation

    NATICK, Mass., June 23 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today welcomed progress on a number of pieces of legislation that will help service veterans and the active armed forces better manage the challenges of chronic pain. The U.S. Senate has recently passed the Veterans Mental Health Improvements...

    Articles 2008-06-23

  • Saints Capital to Acquire Interests in Fifty-Four Companies From Boston Scientific Corporation

    Saints Capital, a leading secondarydirect investment firm, today announced that it has signed a definitiveagreement to acquire interests in fifty-four companies from BostonScientific Corporation, (NYSE: BSX), a worldwide developer, manufacturerand marketer of medical devices. "Boston Scientific has made a number of investments in high qualitycompanies and we are excited...

    Articles 2008-06-19

  • Boston Scientific Announces Agreements to Sell Non-Strategic Investments

    Transactions further Company's plans to focus on core businesses and increase shareholder value NATICK, Mass., June 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that it has signed a definitive agreement to sell its investments in a portfolio of companies, subject to certain closing and other...

    Articles 2008-06-19

  • Swedish medical systems provider Getinge AB relocates manufacture of cardiac surgery products from Puerto Rico to New Jersey

    NORDIC BUSINESS REPORT-18 June 2008-Swedish medical systems provider Getinge AB relocates manufacture of cardiac surgery products from Puerto Rico to New JerseyC1994-2008 M2 COMMUNICATIONS LTD http://www.m2.com Swedish medical systems provider Getinge AB (OMX Stockholm: GETI B) announced on Wednesday (18 June) that its business area Medical Systems has...

    Articles 2008-06-18

  • Incorporated: 1979
  • CEO: Mr. James R. Tobin

Boston Scientific is a developer, manufacturer and marketer of medical devices that are used in a variety of interventional medical specialties including interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology and neuromodulation. Co.'s products are offered for sale mainly by three business groups: Cardiovascular, which includes its interventional cardiology, cardiac rhythm management and cardiovascular divisions; Endosurgery, which includes its oncology, endoscopy and urology/gynecology divisions; and Neuromodulation, which includes its auditory and pain management divisions.

Key Competitors

Boston Scientific Corp. Company Info

Board of Directors

Mr. Peter M. Nicholas

Chairman

Mr. James R. Tobin

Mr. John E. Abele

Mr. Joel L. Fleishman

Dr. Kristina M. Johnson Ph.D.

Dr. Ernest Mario Ph.D.

Dr. Uwe E. Reinhardt

Ms. Ursula M. Burns

Ms. Nancy-Ann DeParle

Mr. J. Raymond Elliott

Dr. Marye Anne Fox Ph.D.

Mr. Ray J. Groves

Mr. N. J. Nicholas Jr.

Mr. John E. Pepper Jr.

Senator Warren B. Rudman

Contact Information

One Boston Scientific Place

Natick, MA

http://www.bsci.com

508 650-8000

NAICS Code

Surgical and Medical Instrument Manufacturing: 339112